These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6892191)

  • 21. [Phase II study of carboplatin in genitourinary cancer. Urological Cooperative Study Group on Carboplatin].
    Niijima T; Tazaki H
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2305-11. PubMed ID: 3044277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II evaluation of cis-dichlorodiammineplatinum(II) in advanced malignancies of the genitourinary and gynecologic organs: a Southwest Oncology Group Study.
    Rossof AH; Talley RW; Stephens R; Thigpen T; Samson MK; Groppe C; Eyre HJ; Fisher R
    Cancer Treat Rep; 1979; 63(9-10):1557-64. PubMed ID: 498155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bropirimine (U-54461S) early phase II clinical studies--to investigate the efficacy and safety of bropirimine treatment on various malignant tumors (urological, hematologic, and dermal cancers)].
    Furue H; Machida T; Masaoka T; Ikeda S
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):67-75. PubMed ID: 9020948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial cisplatin, doxorubicin, and cyclophosphamide (CAP) in the treatment of urothelial transitional cell carcinoma.
    Campbell M; Baker LH; Opipari M; Al-Sarraf M
    Cancer Treat Rep; 1981; 65(9-10):897-9. PubMed ID: 7196800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phase-II-study with cis-diamminedichloroplatinum (II) in the treatment of advanced malignant lymphomas].
    Cavalli F; Jungi WF; Sonntag RW; Nissen NI; Holland JH
    Schweiz Med Wochenschr; 1980 Jul; 110(27-28):1067-70. PubMed ID: 7191577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ototoxicity of cis-diammine glycolato platinum, 254-S].
    Horiuchi M; Miyake H; Ota K
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1327-32. PubMed ID: 1503488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A new cytostatic agent: cis-dischlorodiamin platinum II (DDP)].
    Gallmeier WM; Bruntsch U
    MMW Munch Med Wochenschr; 1979 May; 121(18):624-7. PubMed ID: 108586
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chemotherapy and radiotherapy for urological cancer].
    Miyanaga N; Tsukamoto S; Hattori K; Kawai K; Shimazui T; Uchida K; Akaza H
    Gan To Kagaku Ryoho; 2002 May; 29(5):709-16. PubMed ID: 12040674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: a Southwest Oncology Group Study.
    Rossof AH; Coltman CA; Jones SE; Talley RW
    Cancer Treat Rep; 1979; 63(9-10):1605-8. PubMed ID: 498159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with solid tumors. Multi-Institutional Cooperative Study].
    Saito T; Kasai Y; Wakui A; Furue H; Majima H; Nitani H; Niijima T; Takeda C; Abe O; Koyama Y
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1060-9. PubMed ID: 3963850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A cooperative phase I-II study of HLBI in patients with malignant tumors].
    Kimura K
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1324-31. PubMed ID: 6329104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cis-dichlorodiammineplatinum(II) in advanced bladder cancer.
    Yagoda A; Watson RC; Gonzalez-Vitale JC; Grabstald H; Whitmore WF
    Cancer Treat Rep; 1976 Jul; 60(7):917-23. PubMed ID: 1009522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intra-arterial infusion of antineoplastic agents in the treatment of urogenital cancer].
    Uyam T; Moriwaki S
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):415-20. PubMed ID: 7184407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of etoposide for pulmonary metastases from urogenital tract cancer].
    Fujita K; Murayama T; Sayama T
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2438-41. PubMed ID: 6497402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Phase II study with cisplatin in advanced stomach and colon carcinoma. Cooperative Study Group of Cisplatin for Stomach and Colon Carcinoma].
    Ishibiki K; Kumai K; Kodaira S; Abe O; Yamamoto K; Oouchi T; Fukaya Y; Kimura K; Takamatsu K; Ootsuka E
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3185-93. PubMed ID: 2675769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chemotherapy of non-small-cell bronchial cancer with a combination of Cis-diamminedichloroplatinum (II) and VP 16-213].
    Joss R; Goldhirsch A; Cavalli F; Weber W; Kaplan S; Obrecht JP; Sonntag R; Brunner KW
    Schweiz Med Wochenschr; 1981 Sep; 111(36):1331-4. PubMed ID: 7197802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Guideline for proper use of antineoplastic agents. Urologic cancer].
    Akaza H; Miyanaga N
    Gan To Kagaku Ryoho; 2002 Jun; 29(6):1055-64. PubMed ID: 12109446
    [No Abstract]   [Full Text] [Related]  

  • 38. [Bropirimine (U-54461S) late phase II clinical study for carcinoma in situ of the bladder. Japan Bropirimine Study Group].
    Akaza H; Shimazaki J; Tashiro K; Kotake T; Okajima E; Kagawa S; Machida T
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):77-85. PubMed ID: 9020949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cis-platinum in the treatment of testicular and other cancers.
    Williams SD; Einhorn LH
    Adv Intern Med; 1982; 27():531-45. PubMed ID: 7041553
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical evaluation of M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy for advanced urothelial cancer].
    Mikami K; Nakagawa S; Takada H; Ebisui K; Sugimoto K; Watanabe H; Maegawa M; Nakao M
    Hinyokika Kiyo; 1994 Apr; 40(4):303-7. PubMed ID: 8191968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.